SCHEMBL7095181

SCHEMBL7095181

NCCN(Cc1ccccc1)c1ccccn1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.69
ADRA2A P08913 3/20 0.69
DRD1 P21728 3/20 0.69
SLC6A4 P31645 3/20 0.69
SLC6A3 Q01959 3/20 0.69
KCNH2 Q12809 3/20 0.69
SLC6A2 P23975 2/20 0.69
ADRA1A P35348 2/20 0.69
HTR2A P28223 2/20 0.69
HRH1 P35367 2/20 0.69
ADRA2B P18089 1/20 0.69
ADRA2C P18825 1/20 0.69
OPRK1 P41145 1/20 0.69
KDM4E B2RXH2 4/20 0.68
LMNA P02545 3/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
MAPK1 P28482 1/20 0.68
CYP2D6 P10635 3/20 0.55
TSHR P16473 3/20 0.55
CYP1A2 P05177 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10652605 0.90 GBA1 (0.66) CHRM2ADRA2ADRD1SLC6A4SLC6A3
SCHEMBL10652606 0.89 CHRM2 (0.64) CHRM2ADRA2ADRD1SLC6A4SLC6A3
SCHEMBL9866638 0.88 CYP2D6 (0.72) CHRM2ADRA2ADRD1SLC6A4SLC6A3
Tripelennamine SCHEMBL15270438 0.86 CHRM2 (0.89) CHRM2ADRA2ADRD1SLC6A4SLC6A3
SCHEMBL28590382 0.86 CHRM2 (0.72) CHRM2ADRA2ADRD1SLC6A4SLC6A3
SCHEMBL9574744 0.84 LMNA (0.76) CHRM2ADRA2ADRD1SLC6A4SLC6A3
SCHEMBL11700168 0.83 CHRM2 (0.69) CHRM2ADRA2ADRD1SLC6A4SLC6A3
Tripelennamine SCHEMBL17970 0.82 CHRM2 (1.00) CHRM2ADRA2ADRD1SLC6A4SLC6A3
Tripelennamine SCHEMBL29600775 0.82 CHRM2 (1.00) CHRM2ADRA2ADRD1SLC6A4SLC6A3
SCHEMBL10753463 0.81 GBA1 (0.56) CHRM2ADRA2ADRD1SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1286967-A1 CYCLOHEXANE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LTD. (GB) 2003-03-05 EP disclosed
WO-2001087838-A1 CYCLOHEXANE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LIMITED (GB) 2001-11-22 WO disclosed
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0113572-B1 PYRIDINE DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1988-02-03 EP disclosed
EP-0112704-B1 PYRIDINE DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1987-10-07 EP disclosed
US-4659725-A 3-(2-pyridylaminoalkylamino)cyclobutenediones and pyridones useful as histamine H1 -antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1987-04-21 US disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed
US-4607106-A 3-(2-pyridylaminoalkylamino)thiazoles useful as histamine H1 -antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1986-08-19 US disclosed
US-4547506-A 2-Pyridylaminoakylamino-4-pyrimidones useful as histamine H1 -antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-10-15 US disclosed
US-4532246-A 2-(2-Pyridylaminoalkylamino)-4-pyrimidones SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-07-30 US disclosed
EP-0113572-A2 Pyridine derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1984-07-18 EP disclosed
EP-0112704-A2 Pyridine derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1984-07-04 EP disclosed